CAMSAP1

Across TCGA pan-cancer cohorts, CAMSAP1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CAMSAP1 data layer compared with 25 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CAMSAP1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated CAMSAP1 expression acts as an unfavorable survival marker, although some lineages such as LSCC and CCRCC show a favorable association.

LUAD, PDAC, and LSCC are the cancer types where CAMSAP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.620	0.904	<.001	62	view →
PDAC	OS	Median	II,III,IV	0.723	0.930	.012	39	view →
LSCC	DFS	Median	III,IV	0.868	0.504	.026	5	view →
CCRCC	DFS	Median	All	0.979	0.887	.024	2	view →
UCEC	OS	Tertile	All	1.000	0.921	.040	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CAMSAP1–LUAD (OS)

Open the LUAD breakdown →